Tirzepatide Helps Patients With OSA and Obesity Achieve OSA Remission
Tirzepatide treatment may lead to OSA remission or mild nonsymptomat…
Daewoong Pharmaceutical Co., Ltd. Announces Positive Safety Review for Bersiporocin
Daewoong Pharmaceutical announced that its idiopathic …
SC gives Vodafone Idea a breather
Vodafone Idea welcomed the decision, looking forward to working with the DoT to resolve the matter for i…
Comet 3I/ATLAS Approaching the Sun
The interstellar object 3I/ATLAS is expected to approach the Sun on October 29 and 30.
It will p…
Rethinking the Flat Datum: Designing Space with Incline and Intent
Explore innovative architecture that challenges flat surfaces, creating…
Managing Benign Prostatic Hyperplasia: Your BPH Treatment Options
Struggling with frequent bathroom trips or a weak urine stream? Learn ho…
Quinte Business Achievement Awards Celebrate Business Excellence
The 29th Annual Quinte Business Achievement Awards (QBAA) took place on O…
2025 Next-Gen Solution Provider Leaders
For the sixth year, we present CRN’s Next-Gen Solution Provider Leaders list, recognizing today’s …
Tapering Methotrexate Is Feasible in Stable RA With Careful Monitoring
Long-term flare risk and remission rates did not differ between pat…
Lupus Foundation of America Honors Outstanding Achievements in Lupus Research
The Lupus Foundation of America (LFA) celebrated exceptional…